What vaccines are available for COVID-19?

Reading time: 2 min

A major global effort is underway to accelerate the development of vaccines to protect against the new coronavirus (SARS-CoV-2). The European Medicines Agency (EMA) is the organisation responsible for ensuring the scientific evaluation, supervision and safety monitoring of medicinal products for human and veterinary use in the European Union (EU). The vaccines will be procured jointly by all the countries in the European Union, coordinated by the European Commission.

There are currently four COVID-19 vaccines authorised in the European Union, the Pfizer/BioNTech COMIRNATY, the Moderna vaccine and the Oxford/AstraZeneca vaccine and the Janssen vaccine.

PHARMACEUTICAL COMPANY TYPE OF VACCINE IMMUNISATION SCHEDULE PROCESS
Pfizer/BioNTech COMIRNATY mRNA encoding S protein encapsulated in lipid nanoparticles.

2 doses

0-21 days
Authorised
Moderna mRNA encoding S-protein encapsulated in lipid particles.

2 doses

0-28 days
Authorised
Oxford/Astrazeneca Non-replicative chimpanzee adenovirus carrying the S-protein.

2 doses

0-28 days
Authorised
J&J/Janssen Human adenovirus carrying the S-protein.  1 or 2 doses Authorised
Sanofi/GSK S protein purified with the AS03 adjuvant

2 doses

0-28 days
Phase III
Novamax S-protein nanoparticle with saponin-based M1-matrix adjuvant

2 doses

0-21 days
Phase III
Curevac mRNA encoding a stabilised form of S-protein encapsulated in lipid nanoparticles

2 doses

0-28 days
Phase III

 

Interacción con el doctor Felipe García sobre las vacunas COVID-19

¿Cuáles son los tres tipos principales de vacunas COVID-19?

¿Qué pasa si se rompe la cadena de frío de las vacunas COVID-19?

¿Cuál ha sido el proceso de fabricación de las vacunas COVID-19?

¿Cómo se han podido fabricar las vacunas COVID-19 tan rápido?

¿Cómo funciona la inmunidad de grupo?

¿Cuáles son los efectos secundarios leves de las vacunas COVID-19?

¿Son seguras las vacunas de la COVID-19? 

Substantiated information by:

Antoni Trilla
Eduard Vieta Pascual
Josep Maria Peri
Maica Rubinat
Mariona Violan

Published: 12 March 2020
Updated: 12 March 2020

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.